| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.73T | 1.81T | 1.75T | 1.88T | 1.61T | 1.21T |
| Gross Profit | 377.26B | 388.29B | 370.80B | 381.49B | 378.74B | 293.84B |
| EBITDA | 152.62B | 186.12B | 183.24B | 197.27B | 204.58B | 150.44B |
| Net Income | 17.86B | 32.24B | 50.00B | 82.94B | 109.99B | 57.87B |
Balance Sheet | ||||||
| Total Assets | 2.10T | 2.15T | 2.22T | 2.07T | 1.93T | 1.56T |
| Cash, Cash Equivalents and Short-Term Investments | 198.75B | 209.23B | 210.29B | 186.31B | 181.15B | 195.99B |
| Total Debt | 696.42B | 737.98B | 756.76B | 738.25B | 666.09B | 510.22B |
| Total Liabilities | 1.12T | 1.18T | 1.23T | 1.18T | 1.13T | 875.97B |
| Stockholders Equity | 854.37B | 848.28B | 862.85B | 786.83B | 712.65B | 607.92B |
Cash Flow | ||||||
| Free Cash Flow | 82.72B | 62.09B | 7.35B | -36.62B | -23.63B | 97.74B |
| Operating Cash Flow | 209.74B | 200.50B | 161.34B | 101.24B | 92.58B | 174.32B |
| Investing Cash Flow | -176.71B | -165.01B | -123.94B | -106.34B | -205.23B | -77.56B |
| Financing Cash Flow | -40.38B | -74.44B | -26.02B | 2.54B | 89.22B | -68.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥362.83B | 10.08 | 9.34% | 4.44% | -0.48% | -35.29% | |
75 Outperform | ¥764.00B | 21.71 | 12.15% | 1.55% | 2.62% | 2.81% | |
74 Outperform | ¥272.31B | 10.32 | 5.47% | 3.48% | 2.60% | 9.50% | |
67 Neutral | ¥1.11T | 21.31 | 3.63% | 4.04% | -1.17% | ― | |
64 Neutral | ¥736.77B | 40.98 | 2.02% | 3.92% | -4.63% | -65.11% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | $553.56B | -73.86 | -1.15% | 3.56% | -6.83% | -123.67% |
Mitsui Chemicals, Inc. announced a two-for-one stock split to make its shares more affordable and expand its investor base. The company also revised its dividend forecast in line with the stock split, although there is no effective change from the previous forecast, indicating a strategic move to maintain shareholder value.
Mitsui Chemicals reported a decline in sales revenue and operating income for the first half of FY2025 compared to the previous year. The company has undergone organizational reforms and segment revisions, impacting its financial performance. Despite the challenges, certain segments like ICT solutions showed growth, while others like basic & green materials experienced significant declines. The company also announced a two-for-one stock split, affecting dividend forecasts.